Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis after COVID-19 Vaccination

We report the case of a patient who developed antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) after receiving the coronavirus disease 2019 (COVID-19) vaccine BNT162b (Pfizer–BioNTech). A 37-year-old Japanese woman had been taking propylthiouracil for Graves’ disease. She had e...

Descripción completa

Detalles Bibliográficos
Autores principales: Okuda, Saki, Hirooka, Yasuaki, Sugiyama, Masafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402331/
https://www.ncbi.nlm.nih.gov/pubmed/34451967
http://dx.doi.org/10.3390/vaccines9080842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402331/
https://www.ncbi.nlm.nih.gov/pubmed/34451967
http://dx.doi.org/10.3390/vaccines9080842

Ejemplares similares